Vaccinations Related Content

Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.

Examining existing approved compounds to treat Covid-19 can significantly speed up the development of drugs.

The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trials for three mRNA HIV vaccines.

Pfizer said all profits from Russia would go to "humanitarian support" for Ukraine, with future clinical trials now off the table.

Data finds that three vaccine doses can give 86% protection against the Omicron variant, reducing the chances of severe COVID-19 and death.

Separate to WHO efforts to conduct a technology transfer, Moderna signed a Memorandum of Understanding with Kenya to build the first mRNA factory in Africa.

COVID vaccine rollout led to vaccine inequalities in UK ethnic minority groups, with a decline in people’s willingness to take up vaccination.

In this article, we explain the five main Omicron symptoms - while looking at why the variant is still dominant in global public health.

The World Health Organisation announced that Bangladesh, Indonesia, Pakistan, Serbia and Vietnam would join the mRNA technology transfer scheme.

BioNTech reveal plans to ship mobile mRNA vaccine factories to some countries in Africa - with vaccine manufacturing expected only in late 2023.

Having just one dose of the COVID-19 vaccine significantly reduced multiple psychological distress factors, improving the well-being and safety of recipients.

COVID-19 case numbers need to be far lower than current rates before lifting mask mandates in US elementary schools according to new research

Across the US, those living in rural counties have been more affected by variants of the COVID-19 vaccine, with a faster rate of spread as well as more deaths due to lower rates of vaccination.

A human trial, done via purposeful infection of 36 people, found that the COVID virus can infect the throat just 40 hours after entering the body.

Vaccinated adults with COVID-19 had less severe illness during the omicron surge compared with unvaccinated adults ­– who were more likely to need intensive care.

Academic Research Scholar Dr Wendy Purcell, places the spotlight on COVID-19 variants and vaccines.

Despite healthcare workers experiencing the negative effects of the COVID-19 virus, many did not intend on being vaccinated – new research highlights that their outlooks have changed.

The NHS has opened bookings for a fourth vaccine dose, to 400,000 severely immunosuppressed people across the country.

Data from an ongoing UK trial finds 99% of COVID cases are Omicron, described as "almost complete replacement of Delta".

According to the Boston University School of Public Health, there is no link between COVID vaccination and fertility.